RedHill Biopharma Ltd.RDHLNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-26.7%
5Y CAGR-51.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-26.7%/yr
vs -46.1%/yr prior
5Y CAGR
-51.9%/yr
Recent acceleration
Acceleration
+19.4pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.37 | -38.2% |
| 2023 | 2.22 | +14.4% |
| 2022 | 1.94 | -44.2% |
| 2021 | 3.48 | -65.3% |
| 2020 | 10.04 | -81.2% |
| 2019 | 53.29 | +95.7% |
| 2018 | 27.23 | -33.8% |
| 2017 | 41.10 | -98.1% |
| 2016 | 2129.28 | -97.6% |
| 2015 | 87976.85 | - |